Apricus Biosciences Inc (APRI) 1.84 $APRI
Apricus Biosciences Announces $11 Million Registered Direct Offering With Sarissa Capital Management LP
GlobeNewswire - Wed Feb 11, 9:56AM CST
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into definitive agreements with affiliates of Sarissa Capital Management LP and an additional accredited investor, in a registered direct offering of 6,043,955 shares of common stock and warrants to purchase up to 3,021,977 shares of common stock. The shares and warrants are being sold in combination, consisting of one share of common stock and a warrant to purchase .50 of a share of common stock, at an offering price of $1.82 for expected gross proceeds of approximately $11.0 million. The warrants will become exercisable commencing six months and one day from the date of issuance, expire seven years after the date of issuance and have an exercise price of $1.82 per share. The offering price and exercise price represent the closing price of the Company's common stock as of February 10, 2015. The offering is expected to close on or about February 13, 2015, subject to customary closing conditions.
APRI: 1.84 (-0.08)
Apricus closes direct equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:46AM CST
APRI: 1.84 (-0.08)
Can The Uptrend Continue for Apricus (APRI)?
Apricus Biosciences Announces $11 Million Registered Direct Offering With Sarissa Capital Management LP
GlobeNewswire - Wed Feb 11, 9:56AM CST
Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into definitive agreements with affiliates of Sarissa Capital Management LP and an additional accredited investor, in a registered direct offering of 6,043,955 shares of common stock and warrants to purchase up to 3,021,977 shares of common stock. The shares and warrants are being sold in combination, consisting of one share of common stock and a warrant to purchase .50 of a share of common stock, at an offering price of $1.82 for expected gross proceeds of approximately $11.0 million. The warrants will become exercisable commencing six months and one day from the date of issuance, expire seven years after the date of issuance and have an exercise price of $1.82 per share. The offering price and exercise price represent the closing price of the Company's common stock as of February 10, 2015. The offering is expected to close on or about February 13, 2015, subject to customary closing conditions.
APRI: 1.84 (-0.08)
Apricus closes direct equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:46AM CST
APRI: 1.84 (-0.08)
Can The Uptrend Continue for Apricus (APRI)?
